😊 My experience with PrognosDx Health was excellent. The website provided all the necessary information and the services offered are exceptional. I highly recommend them! 😊
Ask AI about PrognosDx Health
AI-generated from reviews on this page. Verify anything important with the company directly.
I had a great experience with PrognosDx Health! Their website is user-friendly and their services are top-notch. The information provided was thorough and accurate. I highly recommend them.
PrognosDx Health is simply amazing! Their website is informative and user-friendly. Their services are exceptional and the results are accurate. I couldn't be happier with the service provided. 👍🏻
The service provided by this company is exceptional. The website is easy to navigate, and the information provided is comprehensive. I am very satisfied with PrognosDx Health.
The service I received from this company was exceptional. The website provided all the necessary information, and the results were accurate. Highly recommend PrognosDx Health!
I'm really impressed with the services provided by PrognosDx Health. The website is user-friendly and the results are accurate. Keep up the great work! 👍🏻
I had a great experience with PrognosDx Health. The information provided on their website was comprehensive and easy to understand. I highly recommend them! 😊
I had a wonderful experience with this company. The information provided on their website was comprehensive and easy to understand. The services provided by PrognosDx Health are top-notch.
News
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
Widgets
Get the widget for your site →About PrognosDx Health
PrognosDx Health, Inc., a biotechnology company, develops and commercializes epigenetic tests based on histone modification patterns. The company also provides services, such as pharmaceutical research-clinical sample analysis, clinical patient sample analysis tests for other cancers, and prostate cancer patient prognosis test. Its products are used in the development of cancer prognostic assays, therapeutic response prediction assays, and research tools and reagents. The company’s tissue-based global cellular histone biomarkers are prognostic for various cancers, such as prostate, pancreatic, breast, bladder, kidney, gastrics, colon, and lung cancer. PrognosDx Health, Inc. was incorporated in 2008 and is based in Palo Alto, California.
- Website
- prognosdx.com
- kt@prognosdx.com